Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | +6.99% | +4.79% | -6.13% |
08/05 | InflaRx N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
21/03 | Transcript : InflaRx N.V. - Special Call |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
8.42Cr | - | - | ||||
12TCr | ||||||
11TCr | ||||||
2.43TCr | - | |||||
2.2TCr | - | |||||
1.82TCr |
- Stock Market
- Equities
- IFRX Stock
- Charts InflaRx N.V.
- Sector Chart